Vasovagal reactions after COVID-19 vaccination in Japan

Mai Okuyama,Saeko Morino,Kaori Tanaka,Haruna Nakamura-Miwa,Sayaka Takanashi,Satoru Arai,Masaki Ochiai,Koji Ishii,Motoi Suzuki,Akira Oka,Tomohiro Morio,Keiko Tanaka-Taya
DOI: https://doi.org/10.1016/j.vaccine.2022.08.056
IF: 4.169
2022-09-29
Vaccine
Abstract:Coronavirus disease 2019 (COVID-19) vaccine administration started in February 2021 in Japan. As of December 2021, approximately 75% of the population aged ≥12 years had received two doses of vaccine. We conducted a study to investigate vasovagal reactions (VVR) after COVID-19 vaccination using data on adverse events following immunization. The crude reporting rate of VVR (cases/1,000,000 doses) after vaccination was 9.6 in all age groups combined, and was more frequent in the younger age groups: 28.6 and 37.2 in individuals aged 10-19 years and 20-29 years, respectively. In individuals aged 10-29 years, the rate was similar in males and females (33.0 and 34.2, respectively, p = 0.53); but was higher after dose 1 than after dose 2 (57.4 and 8.8, respectively, p < 0.001). Based on these results, caution needs to be exercised when vaccinating adolescents and young adults, especially with dose 1 of COVID-19 vaccines.
What problem does this paper attempt to address?